David S. Perlin

4.1k total citations · 2 hit papers
53 papers, 1.5k citations indexed

About

David S. Perlin is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, David S. Perlin has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 30 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in David S. Perlin's work include Antifungal resistance and susceptibility (29 papers), Fungal Infections and Studies (22 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). David S. Perlin is often cited by papers focused on Antifungal resistance and susceptibility (29 papers), Fungal Infections and Studies (22 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). David S. Perlin collaborates with scholars based in United States, Netherlands and Austria. David S. Perlin's co-authors include Amir Arastehfar, Milena Kordalewska, Martin Hoenigl, Mohammad Taghi Hedayati, Macit İlkit, Farnaz Daneshnia, Agostinho Carvalho, Steven Park, M. Hong Nguyen and Mihai G. Netea and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

David S. Perlin

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The importance of antimicrobial resistance in medical mycology

2022 136 citations Neil A. R. Gow, Judith Berman et al. Nature Communications profile →
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

2023 125 citations Farnaz Daneshnia, Macit İlkit et al. profile →

Peers

Countries citing papers authored by David S. Perlin

Since Specialization

Citations

This map shows the geographic impact of David S. Perlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Perlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Perlin more than expected).

Fields of papers citing papers by David S. Perlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Perlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Perlin. The network helps show where David S. Perlin may publish in the future.

Co-authorship network of co-authors of David S. Perlin

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Perlin. A scholar is included among the top collaborators of David S. Perlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Perlin. David S. Perlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel cellular tool for screening human pan-coronavirus antivirals 2025 ·Antiviral Research ·Ching‐Wen Chang, (unknown), Madhuvika Murugan, (unknown), (unknown), Steven Park, David S. Perlin	0
2	Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discovery 2025 ·SLAS DISCOVERY ·(unknown), Nadine Álvarez, Steven Park, Madhuvika Murugan, David S. Perlin	0
3	Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus Candida glabrata 2024 ·mBio ·Amir Arastehfar, Farnaz Daneshnia, (unknown), (unknown), Mostafa Salehi, David S. Perlin, Macit İlkit, Cornelia Lass‐Flörl, Michael K. Mansour	4
4	Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology 2023 ·Population Health Management ·Harvey W. Kaufman, William A. Meyer, Nigel J. Clarke, Jeff Radcliff, Christopher M. Rank, James Freeman, Marcia Eisenberg, (unknown), William G. Morice, David M. Briscoe, David S. Perlin, Jay G. Wohlgemuth	4
5	Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey 2023 ·Viruses ·José R. Mediavilla, (unknown), Annie Lee, (unknown), (unknown), (unknown), (unknown), Michael C. Zody, André Corvelo, Dayna M. Oschwald, Amy Baldwin, Samantha Fennessey, (unknown), Thomas Kirn, Liang Chen, Yanan Zhao, Kar Fai Chow, Tom Maniatis, David S. Perlin, Barry N. Kreiswirth	4
6	Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), David S. Perlin, Jyothi F. Nagajyothi	7
7	A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens 2022 ·Antimicrobial Agents and Chemotherapy ·Steven Park, Riccardo Russo, (unknown), (unknown), Matthew Zimmerman, Véronique Dartois, Natalia Kurepina, Barry N. Kreiswirth, Eric Singleton, Shaogang Li, Nisha Mittal, (unknown), (unknown), Kristie L. Connolly, Ann E. Jerse, Joel S. Freundlich, David S. Perlin	8
8	Histone Acetylation Regulator Gcn5 Mediates Drug Resistance and Virulence of Candida glabrata 2022 ·Microbiology Spectrum ·Shu-Ying Yu, Padmaja Paderu, Annie Lee, (unknown), Kelley R. Healey, Liang Chen, David S. Perlin, Yanan Zhao	13
9	The importance of antimicrobial resistance in medical mycology breakdown → 2022 ·Nature Communications ·Neil A. R. Gow, (unknown), Judith Berman, Alix T. Coste, Christina A. Cuomo, David S. Perlin, Tihana Bicanic, Thomas S. Harrison, Nathan P. Wiederhold, Michael Bromley, Tom Chiller, (unknown)	136
10	Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China 2022 ·Emerging Microbes & Infections ·(unknown), Meng Xiao, David S. Perlin, Yanan Zhao, Minya Lu, Yi Li, Zhengyu Luo, (unknown), Shengjie Li, (unknown), Lingli Liu, Hong He, Yun Liu, (unknown), (unknown), Zhongju Chen, Yingchun Xu, Tianshu Sun, Li Zhang	37
11	Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome 2021 ·Journal of Clinical Investigation ·David S. Perlin, Garry A. Neil, Colleen Anderson, (unknown), Shane Raines, Carl F. Ware, H. Jeffrey Wilkins	21
12	Cryo-Electron Tomography of Candida glabrata Plasma Membrane Proteins 2021 ·Journal of Fungi ·Cristina Jiménez‐Ortigosa, Jennifer Jiang, Muyuan Chen, (unknown), Kelley R. Healey, Paul Castellano, (unknown), Steven J. Ludtke, David S. Perlin, Wei Dai	14
13	Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs 2021 ·Journal of Extracellular Vesicles ·(unknown), Iddo Z. Ben‐Dov, Christina Liu, Kenny Ye, Kar Fai Chow, Y.G. Kramer, (unknown), Steven Park, (unknown), (unknown), David S. Perlin, Michèle L. Donato, (unknown), (unknown), Michael G. Poulos, Masood Kamali‐Moghaddam, Olivier Loudig	38
14	A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women 2021 ·Frontiers in Microbiology ·Amir Arastehfar, (unknown), (unknown), Maryam Roudbary, (unknown), Ladan Haghighi, Farnaz Daneshnia, (unknown), (unknown), Mohammad Taghi Hedayati, Huiwei Wang, Wenjie Fang, Agostinho Carvalho, Macit İlkit, David S. Perlin, Cornelia Lass‐Flörl	33
15	Differential Regulation of Echinocandin Targets Fks1 and Fks2 in Candida glabrata by the Post-Transcriptional Regulator Ssd1 2020 ·Journal of Fungi ·Kelley R. Healey, Padmaja Paderu, Xin Hou, (unknown), (unknown), Biren A. Patel, Yanan Zhao, David S. Perlin	15
16	Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure 2020 ·Mycoses ·Amir Arastehfar, Farnaz Daneshnia, Mohammadreza Salehi, (unknown), (unknown), Macit İlkit, Weihua Pan, Ferry Hagen, (unknown), Hatice Türk Dağı, Süleyha Hilmioğlu Polat, David S. Perlin, Cornelia Lass‐Flörl	36
17	Recent Increase in the Prevalence of Fluconazole-Non-susceptible Candida tropicalis Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and Genotyping 2020 ·Frontiers in Microbiology ·Amir Arastehfar, Süleyha Hilmioğlu Polat, Farnaz Daneshnia, Ahmed Ibrahem Hafez, Mohammadreza Salehi, (unknown), (unknown), (unknown), (unknown), (unknown), Dilek Yeşim Metin, Şaban Gürcan, Asuman Bırıncı, Ayşe Nedret Koç, Weihua Pan, Macit İlkit, David S. Perlin, Cornelia Lass‐Flörl	29
18	Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation 2020 ·Biosensors and Bioelectronics ·Xiaotian Tan, (unknown), (unknown), Steven Park, Xuzhou Li, (unknown), Yun‐Lu Sun, Jie Zhang, Maung Kyaw Khaing Oo, David S. Perlin, Xudong Fan	64
19	Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway 2018 ·Antimicrobial Agents and Chemotherapy ·Ashutosh Singh, Kelley R. Healey, (unknown), (unknown), Neelam Sachdeva, Smita Sarma, Anil Kumar, Bansidhar Tarai, David S. Perlin, Anuradha Chowdhary	46
20	Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes 2018 ·Frontiers in Microbiology ·(unknown), Eun Jeong Won, Mi‐Na Kim, Wee Gyo Lee, Kyungwon Lee, Hye Soo Lee, Young Uh, Kelley R. Healey, David S. Perlin, Min Ji Choi, Soo Hyun Kim, Jong Hee Shin	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact